Propel Health, a leading provider of strategic communications and engagement services to the life sciences industry, announced the appointment of Jeff Keller as President of its Medical Affairs business unit. A seasoned healthcare communications executive with over 30 years of experience, Jeff will lead Propel Health’s efforts to expand and innovate in medical affairs including strategy development, scientific communications, and integrated engagement solutions for pharmaceutical and biotech clients.
Jeff brings a proven track record of building high-performing organizations and delivering exceptional growth across the medical communications landscape. Most recently, he served as President of Citrus Scientific, where he led the integration of four acquired businesses, and developed strategic initiatives that resulted in significant organic and new business growth, including high-impact work in gene therapy, oncology, and neuroscience. Jeff also held leadership positions at The Curry Rockefeller Group, ICON plc, and Complete Healthcare Communications Group (CHC), a division of MediMedia.
Also Read: Knipper Health Acquires eBlu to Boost Therapy Platform
“We are thrilled to welcome Jeff Keller to Propel Health,” said Mark Fleischer, CEO of Propel Health. “His depth of experience, leadership in medical affairs and demonstrated success in scaling teams and delivering client value make him the ideal leader for this next phase of our growth. Jeff’s vision and ability to align strategy with operational excellence will further strengthen our position as a trusted partner to the pharmaceutical industry.”
“I’m excited to join Propel Health at such a pivotal time,” said Keller. “The company’s commitment to excellence, innovation, and client partnership aligns perfectly with my passion for medical affairs and scientific storytelling. I look forward to collaborating with the exceptional team at Propel to continue delivering outstanding outcomes for our clients and patients worldwide.”
Source: Businesswire
